{
  "report_rows": [
    {
      "kpi": "Adjusted organic sales growth",
      "prediction": "BEAT",
      "answer": "pred ~3.6% vs. cons 3.15%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~24.8% vs. cons 24.65%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.30 vs. cons $2.24",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.60 midpoint vs. cons $8.60 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted organic sales growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.0% vs. cons 3.0% (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted operating-margin expansion guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~75 bps vs. cons 75 bps (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.6,
  "day5_path": "FADE",
  "day5_rationale": "A modest reported beat\u2014pred ~3.6% organic growth vs. cons 3.15% and pred ~$2.30 EPS vs. cons $2.24\u2014should support an initial positive reaction, but unchanged FY26 guidance at a ~$8.60 midpoint vs. cons $8.60 leaves out-period estimates largely unrevised and limits follow-through.",
  "day5_confidence": "MEDIUM"
}